RYCARFA 50 mg 20 tablets flavored meat (carprofen)
International non-proprietary name: carprofen
Dosage form: tablets for oral administration.
Rycarfa® meat-flavored tablets contain carprofen as an active ingredient – 20 mg, 50 mg and 100 mg in one tablet, and as auxiliary substances – lactose monohydrate, corn starch, red iron oxide, black iron oxide, povidone KZO, sodium starch glycolate, flavor with a smell of meat 10022, silicon colloidal anhydride, talc, magnesium stearate.
In appearance, the drug is a dark brown tablet with dark blotches, with a line on one side and with a beveled edge.
The shelf life of the medicinal product, subject to storage conditions, is 3 years from the date of manufacture.
It is forbidden to use the medicinal product after the expiration date.
Ricarfa® meat-flavored tablets are produced in the form of tablets weighing 76 mg, 190 mg, 380 mg, packaged in blisters of 10 pieces. Blisters of 2 are packed in cardboard boxes. Each package is supplied with instructions for use.
Store the medicinal product in the manufacturer’s sealed packaging, separately from food and feed, in a place protected from direct sunlight, at a temperature from 0 ° C to 25 ° C.
The medicinal product should be kept out of the reach of children.
An unused medicinal product is disposed of in accordance with legal requirements.
Dispensed without a veterinarian’s prescription.
PHARMACOLOGICAL PROPERTIES
Carprofen, which is part of the drug, has anti-inflammatory, analgesic and antipyretic effects, inhibiting cycloxygenase in the arachidonic acid cycle, affecting mainly cycloxygenase-P, which is induced in response to the development of inflammation. As a result, the synthesis of inflammatory prostaglandins, which cause inflammation, swelling and pain, is blocked. In therapeutic doses, carprofen has a much weaker effect on cyclooxygenase-1 and, due to this, does not affect the synthesis of protective prostaglandins. Thus, carprofen does not interfere with normal physiological processes in tissues, stomach, intestines, kidneys and platelets.
When administered orally, carprofen is rapidly absorbed in the gastrointestinal tract and enters the bloodstream, reaching its maximum concentration in the blood plasma 1-3 hours after administration. It is metabolized in the liver, excreted mainly in feces and partially in urine. The half-life of carprofen from the body of dogs is about 10 hours.
APPLICATION PROCEDURE
Ricarfa® meat-flavored tablets are used in dogs for inflammatory and pain syndromes arising from acute and chronic diseases of the musculoskeletal system, as well as as an analgesic and anti-inflammatory agent in the postoperative period.
Contraindication to the use of the drug is an increased individual sensitivity to carprofen, stomach and duodenal ulcers, hemorrhagic syndrome, severe renal failure. For animals with diseases of the heart, kidneys and liver, the drug should be administered under the supervision of a veterinarian.
When working with the drug, you should follow the general rules of personal hygiene and safety measures provided for when working with drugs. At the end of work, you should thoroughly wash your hands with soap and water.
People with hypersensitivity to the components of the drug should avoid direct contact with Ricarfa® meat-flavored tablets.
In case of accidental contact of the drug with the skin or mucous membranes of the eye, they must be rinsed with plenty of water. In case of allergic reactions or accidental ingestion of the drug into the human body, you should immediately contact a medical institution (you should have instructions for use or a label with you).
It is forbidden to use Ricarfa® tablets with meat flavor for puppy females. The possibility of using the drug during the feeding period and in puppies younger than 4 months of age is determined by the veterinarian based on an assessment of the ratio of the expected benefit to the possible risk from the use of the drug.
The drug is administered individually orally at a daily dose of 4.0 mg / kg of carprofen, which is recommended to be divided into two equal parts. After 7 days of treatment, depending on clinical indications, the daily dose can be reduced to 2 mg / kg of animal weight.
The duration of the course of treatment for diseases of the musculoskeletal system depends on the condition of the animal and, under the supervision of a veterinarian, can continue throughout the life of the animal.
When using Ricarfa® meat-flavored tablets, as with other non-steroidal anti-inflammatory drugs, in rare cases, the animal may experience stomach irritation and vomiting.
Overdose in dogs may show symptoms of gastrointestinal disturbances such as vomiting and diarrhea.
The drug should not be administered concurrently with other anti-inflammatory drugs, as well as within 24 hours before their use and 24 hours after the end of their use.
The peculiarities of the action of the drug during its first use and withdrawal have not been established.
Avoid skipping the next dose of the drug, as this can lead to a decrease in therapeutic efficacy. In case of missing one dose, the use of the drug is resumed in the same dosage and according to the same scheme.